Filter
509
Filtered Results: 509
Text search:
Plasmodium
falciparum
Featured
Recommendations
40
New Publications
160
Language
Document type
No document type
220
Studies & Reports
84
Guidelines
78
Manuals
44
Strategic & Response Plan
38
Training Material
20
Fact sheets
11
Infographics
5
Situation Updates
3
App
3
Resource Platforms
3
Countries / Regions
Global
46
India
24
Senegal
21
Latin America and the Carribbean
17
Mozambique
15
Sierra Leone
13
Africa
13
Uganda
13
Burkina Faso
12
Congo, Democratic Republic of
11
Tanzania
10
Ethiopia
10
Ghana
9
Myanmar / Burma
9
Kenya
8
Cameroon
8
Nigeria
8
Venezuela
8
Liberia
8
Zambia
7
Nepal
6
Malawi
6
Cambodia
6
North America
6
Bangladesh
6
South Africa
6
Brazil
5
Guinea
4
Asia
4
Angola
4
Botswana
4
Indonesia
4
Madagascar
4
Zimbabwe
3
Philippines
3
Vietnam
3
Sri Lanka
3
Mali
3
Colombia
2
Thailand
2
Benin
2
Togo
2
China
2
Rwanda
2
Iran
2
Laos
2
Burundi
2
West and Central Africa
2
Middle East and North Africa
2
South–East Asia Region
2
Bolivia
2
Namibia
2
Chad
2
Eswatini/ Swaziland
2
North Macedonia
1
Chile
1
Afghanistan
1
Peru
1
Haiti
1
Germany
1
Western and Central Europe
1
Paraguay
1
France
1
East and Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Guyana
1
Argentina
1
Lebanon
1
Papua New Guinea
1
Russia
1
Yemen
1
Central African Republic
1
South Sudan
1
Somalia
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
250
Clinical Guidelines
52
Public Health
44
Pharmacy & Technologies
30
Women & Child Health
23
Capacity Building
12
Key Resources
10
Toolboxes
Malaria
160
NTDs
24
Pharmacy
14
Planetary Health
12
COVID-19
11
HIV
9
Health Financing Toolbox
9
AMR
8
Caregiver
5
Zika
5
Global Health Education
5
Rapid Response
3
Ebola & Marburg
3
Mental Health
2
Refugee
2
Cholera
2
NCDs
2
Conflict
2
Specific Hazards
1
Natural Hazards
1
In November 2022, WHO launched a strategy to address antimalarial drug resistance in Africa, emphasizing the need for stronger surveillance. While regional monitoring networks have been active in other regions, most in Africa have not convened since 2017–2018. To renew collaboration, WHO organized...
Découverte par Alphonse Laveran en 1880, cette maladie parasitaire demeure en 2022 l’endémie la plus répandue dans les régions tropicales et subtropicales. Selon le rapport mondial sur le paludisme de 2021 de l'OMS, on estime à 232 millions le nombre de cas en 2019 dans 87 pays endémiques, d...
Antimalarial chemotherapy is crucial for reducing morbidity, mortality, and drug resistance, and is the cornerstone of malaria control. Existing antimalarial drugs act at different stages of the parasite’s life cycle. These drugs range from classic agents such as chloroquine and quinine to newer a...
To mark the International Day of the African Child, Medicines for Malaria Venture (MMV) celebrated the inclusion of three of its antimalarial medicines on the WHO Model List of Essential Medicines (EML) and the EML for Children (EMLc). These are two artemisinin-based combination therapies (ACTs) for...
hese are two parallel guidelines, one for small hospitals and another one for large hospitals. In view of heavy burden of malaria and prevalence of drug resistant falciparum malaria in the South-East Asia Region, the guidelines were developed for use by medical personnel who treat severe malaria pat...
This technical note provides guidance on actions to accelerate P. falciparum elimination in areas close to achieving this goal without compromising unified malaria elimination efforts (P. vivax - P. falciparum), while contributing to the country's ultimate goal of eliminating malaria overall.
Relapsing malaria caused by Plasmodium vivax parasites poses a significant challenge to global malaria elimination efforts. About one third of the population remains at risk of contracting P. vivax malaria, and 85% of P. vivax infections stem from reactivated latent parasites, leading to chronic ana...
These are two parallel guidelines, one for small hospitals and another one for large hospitals. In view of heavy burden of malaria and prevalence of drug resistant falciparum malaria in the South-East Asia Region, the guidelines were developed for use by medical personnel who treat severe malaria pa...
Esta nota técnica busca guiar a los programas nacionales de malaria y a las organizaciones implicadas en el apoyo de los esfuerzos para la eliminación de la malaria en la Región de las Américas, a fin de que intensifiquen las acciones políticas/estratégicas e implementen los cambios operativos...
2nd edition. The purpose of this document is to present updated standardized protocols that P. falciparum-endemic countries can use to determine the prevalence of parasites with pfhrp2/3 gene deletions causing negative HRP2 RDT results among symptomatic falciparum patients. The findings should be us...
Ce document intitulé « Diagnostic, traitement et prévention du paludisme : directive pour le personnel médical », publié par les Nations Unies en avril 2019, fournit des recommandations pratiques pour le personnel médical travaillant dans des zones à risque de paludisme. Il décrit les signe...
The Mekong Malaria Elimination (MME) programme is an initiative aimed at supporting Greater Mekong Subregion (GMS) countries – Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, and Yunnan (China) – in achieving the goal of malaria elimination by 2030. Data for this epidemi...
This user guide is designed to provide national malaria control programmes with general information on glucose-6-phosphate dehydrogenase (G6PD) deficiency. Individuals with this condition may be at risk of adverse effects from medicines commonly used to cure Plasmodium vivax malaria, as well as from...
The National Strategic Plan on Malaria Prevention and Elimination Period 2021 – 2025 seeks to build on the previous national successes of the National Institute of Malariology, Parasitology, and Entomology (NIMPE) while addressing current challenges to reduce the overall burden of malaria in the S...
High levels of storage iron may increase malaria susceptibility. This risk has not been investigated in semi-immune adolescents. We investigated whether baseline iron status of nonpregnant adolescent girls living in a high malaria transmission area in Burkina Faso affected malaria risk during the fo...
This report, published in conjunction with a summary overview of results of rounds 1–8, is the eighth and final report in a series of laboratory-based evaluations of rapid diagnostic tests (RDTs) for malaria. It provides a comparative measure of their performance in a standardized way to distingui...
The 2022 report reviews the global malaria diagnostics market and technological landscape to support Unitaid’s 2023–2027 strategy for quality malaria case management. The report highlights the stalled progress of malaria control efforts, the gaps in access to diagnostics and the public health im...
The document provides an overview of malaria in the Americas, describing its transmission, symptoms, vulnerable populations, and regional trends, while highlighting prevention strategies and the efforts of PAHO/WHO and member states to eliminate the disease by 2020.
BMC Medicine (2015) 13:42 DOI 10.1186/s12916-014-0263-6
